Fed. Circ. Mulls Amgen-Sandoz Psoriasis Drug Dispute

The Federal Circuit spend part of its morning Wednesday parsing the definition of "a difference in degree not in kind" in order to decide whether a lower court had erred by...

Already a subscriber? Click here to view full article